This is a parallel, double blind, Phase 3, 2-arm study that is designed to provide additional safety information, assess the durability of treatment response, and provide additional PK and immunogenicity assessments. The primary purpose of this study is to evaluate safety and tolerability of both itepekimab SC Q2W or itepekimab SC Q4W in participants with COPD having completed the treatment period of the clinical studies EFC16750 or EFC16819. A secondary purpose of this study is to provide efficacy outcomes beyond the treatment period of the parent trials EFC16750 and EFC16819. Study details include: * The study duration will be up to 72 weeks * The treatment duration will be up to 52 weeks * A follow-up period of 20 weeks will be conducted * The number of on-site visits will be 7 and the number of phone contacts will be 5
Chronic Obstructive Pulmonary Disease
This is a parallel, double blind, Phase 3, 2-arm study that is designed to provide additional safety information, assess the durability of treatment response, and provide additional PK and immunogenicity assessments. The primary purpose of this study is to evaluate safety and tolerability of both itepekimab SC Q2W or itepekimab SC Q4W in participants with COPD having completed the treatment period of the clinical studies EFC16750 or EFC16819. A secondary purpose of this study is to provide efficacy outcomes beyond the treatment period of the parent trials EFC16750 and EFC16819. Study details include: * The study duration will be up to 72 weeks * The treatment duration will be up to 52 weeks * A follow-up period of 20 weeks will be conducted * The number of on-site visits will be 7 and the number of phone contacts will be 5
A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD
-
Chandler Clinical Research Trials- Site Number : 8401034, Chandler, Arizona, United States, 85286
Noble Clinical Research Site Number : 8401182, Tucson, Arizona, United States, 85704
Antelope Valley Clinical Trials Site Number : 8401003, Lancaster, California, United States, 93534
Downtown L.A. Research Center- Site Number : 8401027, Los Angeles, California, United States, 90017
Allianz Research Institute CO Site Number : 8402061, Aurora, Colorado, United States, 80014
Alpine Clinical Research Center - Boulder - 47th Street- Site Number : 8401180, Boulder, Colorado, United States, 80301
Helix Biomedics- Site Number : 8402049, Boynton Beach, Florida, United States, 33435
Beautiful Minds Clinical Research Center Site Number : 8401201, Cutler Bay, Florida, United States, 33157
Omega Research Consultants - Debary - North Charles Richard Beall Boulevard- Site Number : 8402031, DeBary, Florida, United States, 32713
Direct Helpers Research Center- Site Number : 8402065, Hialeah, Florida, United States, 33012
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
40 Years to 85 Years
ALL
No
Sanofi,
Clinical Sciences & Operations, STUDY_DIRECTOR, Sanofi
2026-12-01